pISSN 1226-6051
eISSN 2508-786X

Table. 3.

Table. 3.

Multiple logistic regression results

Chacateristics CDP

Adjusted OR (95% CI)
Sex Male 1
Female 0.75 (0.61-0.92)

Age(years) 20-39 1
40-49 1.23 (0.69-2.35)
50-59 0.96 (0.55-1.80)
60-69 0.87 (0.50-1.64)
70-74 1.42 (0.82-2.68)
≥75 1.83 (1.02-3.52)

Comorbidity Dyslipidemia
No 1
Yes 1.21 (0.99-1.47)
Coronary artery diseasea
No 1
Yes 2.22 (1.60-3.03)
Chronic heart failure
No 1
Yes 2.71 (1.93-3.72)
Stroke
No 1
Yes 1.60 (0.91-2.61)
Chronic kidney disease
No 1
Yes 4.45 (2.15-8.25)

Insurance NHI 1
MedAid+PVI 1.49 (1.04-2.07)

Institution Tertiary hospital 1
General hospital 0.77 (0.49-1.23)
Clinic 0.52 (0.35-0.79)
Public health 0.63 (0.32-1.24)
Others 0.71 (0.44-1.18)

Specialty Internal medicine 1
Family medicine 1.36 (0.88-2.01)
Others 1.19 (0.86-1.63)

Area Seoul 1
Kyeonggib 0.78 (0.58-1.04)
Gyeongsangc 1.15 (0.87-1.52)
Jeollad 1.13 (0.80-1.58)
Chungcheonge 0.95 (0.65-1.36)
Gangwon 1.27 (0.77-2.01)
Jeju 0.35 (0.06-1.11)

c stastic 0.675

p value of Hosmer-Lemeshow test 0.424

CDP, Class Duplicate Prescription; OR, Odds Ratio; CI, Confidence Interval; NHI, National Health Insurance; MedAid, Medical Aid; PVI, Patriots and Veterans Insurance

a Coronary artery disease; angina and myocardial infarction

b Kyeonggi-do and Incheon Metropolitan City are included

c Kyeongsangnam-do, Kyeongsangbuk-do, Busan Metropolitan City, Ulsan Metropolitan City and Daegu Metropolitan City are included

d Jeollanam-do, Jeollabuk-do and Gwangju Metropolitan City are included

e Chungcheongnam-do, Chungcheongbuk-do, Daejeon Metropolitan City and Sejong City are included

Korean J Clin Pharm 2022;32:125-32 https://doi.org/10.24304/kjcp.2022.32.2.125
© 2022 Korean J Clin Pharm